Cargando…

Association Between Norepinephrine Levels and Abnormal Iron Status in Patients With Chronic Heart Failure: Is Iron Deficiency More Than a Comorbidity?

BACKGROUND: Mechanisms underlying iron homeostasis dysregulation in patients with chronic heart failure remain unsettled. In cardiomyocyte models, norepinephrine may lead to intracellular iron depletion, but the potential association between catecholamines (sympathetic activation markers) and iron m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moliner, Pedro, Enjuanes, Cristina, Tajes, Marta, Cainzos‐Achirica, Miguel, Lupón, Josep, Garay, Alberto, Jimenez‐Marrero, Santiago, Yun, Sergi, Farré, Núria, Cladellas, Mercé, Díez, Carles, Gonzalez‐Costello, Jose, Comin‐Colet, Josep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405646/ https://www.ncbi.nlm.nih.gov/pubmed/30760082 http://dx.doi.org/10.1161/JAHA.118.010887

Ejemplares similares

Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction
por: Alcaide-Aldeano, Alex, et al.
Publicado: (2020)

Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study
por: González-Costello, José, et al.
Publicado: (2018)

Blood Differential Gene Expression in Patients with Chronic Heart Failure and Systemic Iron Deficiency: Pathways Involved in Pathophysiology and Impact on Clinical Outcomes
por: Díez-López, Carles, et al.
Publicado: (2021)

Real-World Epidemiology of Potassium Derangements Among Chronic Cardiovascular, Metabolic and Renal Conditions: A Population-Based Analysis
por: Jiménez-Marrero, Santiago, et al.
Publicado: (2020)

Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients
por: Farré, Núria, et al.
Publicado: (2017)

Neurohormonal activation induces intracellular iron deficiency and mitochondrial dysfunction in cardiac cells
por: Tajes, M., et al.
Publicado: (2021)

Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status
por: Comín-Colet, Josep, et al.
Publicado: (2013)

Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy
por: Díez-López, Carles, et al.
Publicado: (2022)

Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients
por: Ras-Jiménez, Maria del Mar, et al.
Publicado: (2023)

Use of potassium-binder patiromer for up-titration of renin–angiotensin–aldosterone system inhibition therapy in a patient with chronic heart failure and reduced ejection fraction followed in a multidisciplinary integrated chronic care management programme: a case report
por: Jiménez-Marrero, Santiago, et al.
Publicado: (2020)

Systematic review and meta‐analysis of intravenous iron‐carbohydrate complexes in HFrEF patients with iron deficiency
por: Sindone, Andrew, et al.
Publicado: (2022)

Validation of the Spanish version of the questionnaire on Patient Empowerment in Long-Term Conditions
por: Garcimartín, Paloma, et al.
Publicado: (2020)

Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain)
por: Farré, Nuria, et al.
Publicado: (2017)

Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency
por: Macdougall, Iain C., et al.
Publicado: (2020)

Iron deficiency in chronic heart failure: case‐based practical guidance
por: Lam, Carolyn S. P., et al.
Publicado: (2018)

Breaking the 30-day barrier: Long-term effectiveness of a nurse-led 7-step transitional intervention program in heart failure
por: Alcoberro, Lidia, et al.
Publicado: (2023)

Psychosocial factors partially explain gender differences in health‐related quality of life in heart failure patients
por: Tapia, Javier, et al.
Publicado: (2022)

Inequalities by Income in the Prevalence of Cardiovascular Disease and Its Risk Factors in the Adult Population of Catalonia
por: Mullachery, Pricila H., et al.
Publicado: (2022)

Ischemic aetiology, self-reported frailty, and gender with respect to cognitive impairment in chronic heart failure patients
por: González-Moneo, María J, et al.
Publicado: (2016)

Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial‐IRON Trial
por: Núñez, Julio, et al.
Publicado: (2020)

Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection Fraction
por: Cristóbal, Helena, et al.
Publicado: (2023)

Performance of Three Measures of Comorbidity in Predicting Critical COVID-19: A Retrospective Analysis of 4607 Hospitalized Patients
por: Monterde, David, et al.
Publicado: (2021)

Performance of Comprehensive Risk Adjustment for the Prediction of In-Hospital Events Using Administrative Healthcare Data: The Queralt Indices
por: Monterde, David, et al.
Publicado: (2020)

Is Age the Most Important Risk Factor in COVID-19 Patients? The Relevance of Comorbidity Burden: A Retrospective Analysis of 10,551 Hospitalizations
por: Valero-Bover, Damià, et al.
Publicado: (2023)

Adaptación transcultural al español del cuestionario Patient empowerment in long-term conditions
por: Garcimartin, Paloma, et al.
Publicado: (2019)

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency(†)
por: Ponikowski, Piotr, et al.
Publicado: (2015)

Defining quantification methods and optimizing protocols for microarray hybridization of circulating microRNAs
por: Garcia-Elias, Anna, et al.
Publicado: (2017)

Implications of the 2021 ESC cardiovascular risk classification among 283,000 European immigrants living in a low-risk region: a population-based analysis in Catalonia
por: Vela, Emili, et al.
Publicado: (2021)

Impact of non-cardiovascular comorbidities on the quality of life of patients with chronic heart failure: a scoping review
por: Comín-Colet, Josep, et al.
Publicado: (2020)

Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?
por: Sindone, Andrew, et al.
Publicado: (2022)

Prognostic Value of the Acute-to-Chronic Glycemic Ratio at Admission in Heart Failure: A Prospective Study
por: Carrera, Mª José, et al.
Publicado: (2021)

Gender Differences in Health-Related Quality of Life in Patients with Systolic Heart Failure: Results of the VIDA Multicenter Study
por: Garay, Alberto, et al.
Publicado: (2020)

Rationale and design of Ferinject(®) Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia
por: Anker, Stefan D., et al.
Publicado: (2009)

Usefulness of telemedicine-based heart failure monitoring according to “eHealth literacy” domains: insights from the iCOR randomised controlled trial
por: Yun Viladomat, S, et al.
Publicado: (2022)

The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study
por: Comin-Colet, Josep, et al.
Publicado: (2013)

Atrial Fibrillation in Heart Failure Is Associated with High Levels of Circulating microRNA-199a-5p and 22–5p and a Defective Regulation of Intracellular Calcium and Cell-to-Cell Communication
por: Garcia-Elias, Anna, et al.
Publicado: (2021)

Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management
por: Cappellini, Maria Domenica, et al.
Publicado: (2017)

Síndrome de tako-tsubo asociado con COVID-19
por: Oyarzabal, Loreto, et al.
Publicado: (2020)

Tako-tsubo syndrome associated with COVID-19
por: Oyarzabal, Loreto, et al.
Publicado: (2020)

Tratamiento neurohormonal en miocardiopatía de tako-tsubo precipitada por COVID-19. Respuesta
por: Oyarzabal, Loreto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q7bfoqe13dhkbosotbcfumn3e9